Juergen Wolf

Papers

Total Citations

H-Index

About

Juergen Wolf is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for thoracic malignancies, particularly in patients with inoperable early-stage non-small-cell lung cancer (NSCLC). His most cited work, a 2017 study on risk-adapted robotic SBRT, has garnered 36 citations and established a framework for tailoring radiation doses based on tumor location and patient-specific risk factors, significantly improving treatment precision and reducing toxicity. Wolf’s contributions have helped refine SBRT as a standard-of-care alternative for patients who cannot undergo surgery, demonstrating that high-dose, hypofractionated radiation can achieve excellent local control with minimal side effects. His research integrates advanced robotic delivery systems with adaptive planning, pushing the boundaries of non-invasive cancer therapy. Beyond this landmark paper, Wolf has published extensively on optimizing dose fractionation and managing radiation-induced complications, influencing clinical protocols worldwide. His work is particularly notable for its patient-centered approach, balancing efficacy with quality of life. With a citation impact that underscores its clinical relevance, Juergen Wolf remains a pivotal figure in the evolution of lung cancer radiotherapy, inspiring further innovation in precision oncology.